DSFI Stock Overview
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €103.75 |
| 52 Week High | €108.35 |
| 52 Week Low | €76.22 |
| Beta | 0 |
| 1 Month Change | -0.95% |
| 3 Month Change | 9.74% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 4.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| DSFI | AT Chemicals | AT Market | |
|---|---|---|---|
| 7D | 3.1% | 2.9% | 1.2% |
| 1Y | n/a | 2.2% | 5.9% |
Return vs Industry: Insufficient data to determine how DSFI performed against the Austrian Chemicals industry.
Return vs Market: Insufficient data to determine how DSFI performed against the Austrian Market.
Price Volatility
| DSFI volatility | |
|---|---|
| DSFI Average Weekly Movement | 6.4% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in AT Market | 5.0% |
| 10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: DSFI has not had significant price volatility in the past 3 months.
Volatility Over Time: DSFI's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 28,685 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
| DSFI fundamental statistics | |
|---|---|
| Market cap | €28.48b |
| Earnings (TTM) | -€658.00m |
| Revenue (TTM) | €10.63b |
2.7x
P/S Ratio-43.3x
P/E RatioIs DSFI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSFI income statement (TTM) | |
|---|---|
| Revenue | €10.63b |
| Cost of Revenue | €8.02b |
| Gross Profit | €2.61b |
| Other Expenses | €3.27b |
| Earnings | -€658.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 30, 2024
| Earnings per share (EPS) | -2.48 |
| Gross Margin | 24.57% |
| Net Profit Margin | -6.19% |
| Debt/Equity Ratio | 19.2% |
How did DSFI perform over the long term?
See historical performance and comparison